Mary Caffrey is the Executive Editor for The American Journal of Managed Care® (AJMC®). She joined AJMC® in 2013 and is the primary staff editor for Evidence-Based Oncology, the multistakeholder publication that reaches 22,000+ oncology providers, policy makers and formulary decision makers. She is also part of the team that oversees speaker recruitment and panel preparations for AJMC®'s premier annual oncology meeting, Patient-Centered Oncology Care®. For more than a decade, Mary has covered ASCO, ASH, ACC and other leading scientific meetings for AJMC readers.
Mary has a BA in communications and philosophy from Loyola University New Orleans. You can connect with Mary on LinkedIn.
Overcoming Stigma Essential to Improving Payer Coverage for Obesity
April 9th 2016While payer coverage for obesity care has improved since the American Medical Association declared that obesity is a disease, there's still a long way to go. Physician training must improve to eliminate stigma that keeps patients from getting care they need, according to experts who appeared at Patient-Centered Diabetes Care.
Filling Gaps in Diabetes Care With the Retail Clinic
April 8th 2016Growth in retail health clinics reveals unmet medical needs for Americans who lack insurance, who cannot leave work, or who have disconnected with the health system. This growing sector of the health system is diagnosing and treating diabetes cases that would otherwise be missed.
Lancet: Global Diabetes Population Reaches 422M; Most New Cases in Low- and Middle-Income Countries
April 6th 2016While this study focused on calculating the global burden of diabetes, it comes as advocacy groups are stepping up calls for soda taxes marketing limits to rein in the effect of unhealthy food and drink on poor countries.
PCSK9 Inhibitor Cuts Cholesterol for the Statin Intolerant - but Price Not Worth It, JAMA Says
April 3rd 2016Results from the GAUSS-3 trial presented Sunday at the American College of Cardiology should be good news for Amgen, but an editorial in JAMA says the cost of evolocumab exceeds "willingness to pay" limits.
Surprise: Express Scripts Data Show Statin Use Fell After New Cholesterol Guideline
April 3rd 2016The 2013 guideline update from the American College of Cardiology and the American Heart Association drew criticism when it was presented. Data presented in today's poster session at the ACC Scientific Session revealed unexpected results.
Statins Can Cut Heart Attacks in Moderate-Risk Patients, Study Finds
April 2nd 2016Results from the HOPE-3 trial, presented on the opening day of the 65th Scientific Session of the American College of Cardiology, suggest cholesterol-lowering statins could have preventive benefits in broader groups of patients than previously thought.
Horizon, Newark's University Hospital Announce Value-Based Effort for Pregnancies
March 29th 2016The value-based care initiative comes at a crucial time for the safety-net hospital: the vast majority of pregnancies are covered by Medicaid and some are covered by charity care. The latter funding source is being cut in the proposed New Jersey state budget.
Cleveland Clinic Data: Heart Attack Patients Getting Younger, Fatter
March 26th 2016Data showed that patients coming to the world-famous hospital for a heart attack grew younger, sicker, and more obese from 1995 to 2014. Because the researchers have not yet reported socioeconomic status, it is hard to know whether the findings reflect broader trends.
Can Mammograms Also Find Heart Disease?
March 25th 2016Study authors found that women whose mammograms revealed calcium buildup in breast arteries were highly likely to have coronary arterial calcification. This "practice changing" finding could allow doctors to spot early heart disease in women where it otherwise would have been missed.
Bariatric Surgery Outperforms Drugs, Lifestyle Interventions in Reversing Diabetes in Study
March 24th 2016The randmized controlled trial confirms findings in observational studies that gastric bypass provides benefits beyond weight loss, and suggests BMI should not be the only consideration for who should have surgery. The fact that the study is associated with a major US payer is noteworthy.